Semax
Nootropic · By Preptide Pro editorial team · Last updated
Semax is a nootropic peptide, and it is not FDA-approved. A synthetic peptide derived from an ACTH fragment. Studied mainly in Russia for stroke recovery and cognition.
Not FDA-approvedChemistry (PubChem)
| PubChem CID | 9811102 |
|---|---|
| CAS number | 80714-61-0 |
| Molecular formula | C37H51N9O10S |
| Molecular weight | 813.9 g/mol |
| Other names | Semax, ACTH (4-7), Pro-Gly-Pro-, ACTH (4-7), prolyl-glycyl-proline-, Pro-gly-pro-acth (4-7), RefChem:56007, MEHFPGP, Met-Glu-His-Phe-Pro-Gly-Pro, Semax? |
Is Semax FDA-approved?
Not FDA-approved. No matching NDA or BLA was found in openFDA (Drugs@FDA).
How much research is there on Semax?
PubMed lists 234 records for “semax”, of which 4 are tagged as human clinical trials.
| Recent study | Journal | Date |
|---|---|---|
| Quantitative MRI Pharmacokinetic Modeling and MALDI Mass Spectrometry Imaging Biodistribution of a pH Mapping MRI Contrast Agent. | Theranostics | 2026 |
| Synthetic Peptides in Pharmacy Compounding: Analysis of PCAC Recommendations and Industry Safety Standards. | Int J Pharm Compd | 2026 Jul-Aug |
| Multi-Layer Magnetic Shields Based on Fe-Based Nanocrystalline and Co-Based Amorphous Ribbons. | Materials (Basel) | 2026 May 11 |
| Digitally Guided Hybrid Maxillary Expansion with Supragingival Mandibular Miniplates for Class III Correction in Late Adolescents: A Pilot Clinical Study. | J Clin Med | 2026 Apr 17 |
| Therapeutic peptides in gerontology: mechanisms and applications for healthy aging. | Front Aging | 2026 |
Sources
This is general research information, not medical advice. Check with a clinician before using any compound.